MET
58
2
COP
36
2
BEN
36
4
DFS
64
4
CME
59
3
AFL
34
6
GS
65
16
WFC
58
8
AKAM
50
2
ORCL
49
3
PNR
56
2
CAG
34
3
AA
27
5
MSFT
55
2
ETN
64
4
MTB
38
4
BIIB
36
8
PH
60
5
HST
53
4
LOW
42
14
MET
58
2
COP
36
2
BEN
36
4
DFS
64
4
CME
59
3
AFL
34
6
GS
65
16
WFC
58
8
AKAM
50
2
ORCL
49
3
PNR
56
2
CAG
34
3
AA
27
5
MSFT
55
2
ETN
64
4
MTB
38
4
BIIB
36
8
PH
60
5
HST
53
4
LOW
42
14
Financhill
Back

Structure Therapeutics Vs. Nukkleus Industry Stock Comparison

Sell
6

GPCR
Structure Therapeutics

Last Price:
$27.91
Seasonality Move:
-41.18%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
6
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $27.90. The Score for GPCR is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $27.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.72 Sell
Relative Strength Index (14 RSI): 35.5 Sell
Chaikin Money Flow: -1322544 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.51 - 34.27) Sell
Bollinger Bands (100): (33.57 - 40.75) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.68 Sell
20-day SMA: 32.41 Sell
50-day SMA: 35.41 Sell
200-day SMA: 38.71 Sell
8-day EMA: 30.31 Sell
20-day EMA: 32.11 Sell
50-day EMA: 34.63 Sell
200-day EMA: 37.98 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.08 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):